(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one

 化学構造式
CAS番号.
化学名:
别名:
英語名:
(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
英語别名:
(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
CBNumber:
CB55986421
化学式:
C21H26O5
分子量:
0
MOL File:
Mol file

(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one 物理性質

融点 :
>171°C (dec.)
貯蔵温度 :
-20°C Freezer, Under inert atmosphere
溶解性:
クロロホルム(少量、加熱、超音波処理)、メタノール(少量)
外見 :
個体
色:
オフホワイトからライトイエロー

安全性情報

(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one 化学特性,用途語,生産方法

使用

(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one is an impurity of budesonide which is a non-halogenated glucocorticoid related to triamcinolone hexacetonide. Used as an antiinflammatory agent.

(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one 上流と下流の製品情報

原材料

準備製品


(8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one 生産企業

Global( 3)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
BOC Sciences 1-631-485-4226; 16314854226
info@bocsci.com United States 14059 65

  • (8S,9S,10R,13S,14S)-17-(2,2-Dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-3H-cyclopenta[a]phenanthren-3-one
Copyright 2017 © ChemicalBook. All rights reserved